2020 Meningitis Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers
The report presents a detailed analysis of the Mononucleosis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Mononucleosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 200 pages and 15 tables
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 200 pages and 15 tables
I. INTRODUCTION
II. WORLDWIDE TEST OVERVIEW, TECHNOLOGIES AND INSTRUMENTATION
A. Background, Diagnostic Tests, Vaccines and Drugs
B. Instrumentation Review: Operating Characteristics, Features and Selling Princes of Leading Infectious Disease Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
III. COUNTRY ANALYSES: SALES AND VOLUME FORECASTS
IV. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
V. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
VI. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
VII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VIII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
GSK Biologicals
Hologic
Leica Biosystems
Lonza
Ortho-Clinical Diagnostics
PerkinElmer
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens Healthineers
Takara Bio
Thermo Fisher
Wako
II. WORLDWIDE TEST OVERVIEW, TECHNOLOGIES AND INSTRUMENTATION
A. Background, Diagnostic Tests, Vaccines and Drugs
B. Instrumentation Review: Operating Characteristics, Features and Selling Princes of Leading Infectious Disease Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
III. COUNTRY ANALYSES: SALES AND VOLUME FORECASTS
IV. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
V. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
VI. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
VII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VIII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
GSK Biologicals
Hologic
Leica Biosystems
Lonza
Ortho-Clinical Diagnostics
PerkinElmer
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens Healthineers
Takara Bio
Thermo Fisher
Wako
More Publications
2017-2021 World CA Tumor Markers Testing Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 4,905.00
March 2017
278 pages
2017-2021 Point-of-Care/POC Infectious Disease Market: Physician Offices, Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers--Supplier Shares, Competitive Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review
US$ 4,950.00
January 2017
795 pages
Clinical Chemistry and Immunodiagnostics Market Players--2017 Market Shares by Country, and Strategic Assessments of Major Suppliers and Emerging Market Entrants
US$ 2,450.00
December 2017
42 pages
Global Coagulation Analyzers and Reagents: US, Europe, Japan-Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities
US$ 27,500.00
November 2019
650 pages
Emerging Tumor Marker Testing Technologies, Country Market Shares, Strategic Profiles of Leading Suppliers, 2019
US$ 3,850.00
July 2019
185 pages
